Moderna cuts 2024 sales forecast, sees low EU vaccine revenue into 2026
Go back to Moderna cuts 2024 sales forecast, sees low EU vaccine revenue into 2026| Marina Biotech, Inc. (NASDAQ: MRNA) | Delayed: 61.34 +0.34 (0.56%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $61.00 | 52 Week High | $0.52 | |||
| Open | $61.17 | 52 Week Low | $0.08 | |||
| Day High | $62.75 | P/E | N/A | |||
| Day Low | $60.25 | EPS | $-3.80 | |||
| Volume | 2,887,736 | |||||
